Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 26, 2021
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
[ Wed, May 26th 2021
] - WOPRAI
Vikram Purohit Maintained (AXSM) at Buy with Increased Target to $105 on, May 26th, 2021
Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Buy with Increased Target from $104 to $105 on, May 26th, 2021.
Vikram has made no other calls on AXSM in the last 4 months.
There is 1 other peer that has a rating on AXSM. Out of the 1 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vikram
- Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $225 on, Tuesday, April 27th, 2021
